Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
000597.SZ
HOLDREMOVENortheast Pharmaceutical Group Co., Ltd. · Healthcare · China · $983M · Avg Vol: $8M/d
Northeast Pharmaceutical is a generic pharmaceutical and API manufacturer. It is highly vulnerable to rising input costs and severe domestic price compression in China, making it a casualty of the shift toward high-moat CDMOs.
COMPANY DESCRIPTION
Northeast Pharmaceutical Group is a major pharmaceutical manufacturer producing active pharmaceutical ingredients (APIs), generic formulations, and nutritional supplements. The company is one of the world's largest producers of Vitamin C and holds a strong domestic position in anti-infective and central nervous system drugs. It operates as a vertically integrated, large-scale industrial player with a significant global export footprint.
FINANCIAL SUMMARY
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | — | 1.3B | 1.2B | 1.1B | 1.0B | -7.0% |
| EPS | — | 0.04 | 0.04 | 0.04 | 0.03 | -10.4% |
| Shares | — | 1.4B | 1.4B | 1.4B | 1.4B | -0.5% |
| Debt | 30M | 330M | 328M | 241M | 317M | 81.0% |
| Equity | — | 674M | 737M | 786M | 817M | 6.6% |
| Op CF | — | 164M | 87M | 112M | 164M | -0.1% |
| Inv CF | — | -38M | -34M | -42M | -13M | — |
| Fin CF | — | -9M | 56M | -170M | -35M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000597.SZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 000597.SZ | Northeast Pharmaceutical Group Co., Ltd.(you) | $983M | 64 | HOLD |
| 600195.SS | China Animal Husbandry Industry Co., Ltd. | $996M | 64 | HOLD |
| 600557.SS | Jiangsu Kanion Pharmaceutical Co.,Ltd. | $1.1B | 65 | HOLD |
| 2186.HK | Luye Pharma Group Ltd. | $1.1B | 61 | HOLD |
| 002550.SZ | Changzhou Qianhong Biopharma CO.,LTD | $1.2B | 66 | BUY |
| 603439.SS | Guizhou Sanli Pharmaceutical Co.,Ltd | $984M | 70 | BUY |
| 688566.SS | Jiangsu Jibeier Pharmaceutical Co., Ltd. | $741M | 65 | BUY |
| 300039.SZ | Shanghai Kaibao Pharmaceutical CO.,Ltd | $822M | 68 | BUY |
| 300725.SZ | PharmaBlock Sciences (Nanjing), Inc. | $1.2B | 60 | HOLD |
| 601089.SS | Beijing Foyou Pharma CO.,LTD | $1.3B | 61 | HOLD |
Peer medians: ROE 4.8% · P/E 27.9x · Gross margin 53.1%